Press Releases
Press Release
Cardiol Therapeutics Closes $22 Million Bought Deal Offering
May 12, 2021
Press Release
Cardiol Announces Upsize to Previously Announced Bought Deal Public Offering
May 06, 2021
Press Release
Cardiol Therapeutics Announces $15 Million Bought Deal Public Offering
May 05, 2021
Press Release
Cardiol Therapeutics Announces First Patient Enrolled in LANCER, a Phase II/III Outcomes Trial in High-risk Patients Hospitalized with COVID-19
April 28, 2021
Press Release
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx™
April 12, 2021
Press Release
Cardiol Therapeutics Announces Filing of 2020 Year-end Financial Statements and MD&A
April 01, 2021
Press Release
Cardiol Therapeutics Appoints Dr. Andrew Hamer as New Chief Medical Officer
March 30, 2021
Press Release
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options
March 02, 2021
Press Release
Cardiol Therapeutics Announces Formation of Data Safety Monitoring and Clinical Endpoint Committees for Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19
January 21, 2021
